Immune Modulation & Natural Biocompounds

Dr. Dorit Avni

Principal Researcher

Dr. Dorit Avni

Dr. Dorit Avni
Immune Modulation & Natural Biocompounds
054-9815556

We strive to understand the mechanisms of  inflammation and cancer  that underlie the involvement of sphingolipids  and to translate these laboratory discoveries into new therapies

 

Latest Publications

p70S6K as a Potential Anti-COVID-19 Target: Insights from Wet Bench and In Silico Studies

Shechter, S., Kumar, R., Trovato, F., Rozen, O., Gage, M. J. & Avni, D.
Cells 13(21)
2024

Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. FASEB J

Huang WC, Liang J, Nagahashi M, Avni D, Yamada A, Maceyka M, Wolen AR, Kordula T, Milstien S, Takabe K, Oravecz T, Spiegel S.
2016

Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors. Immunol Lett

Katz S, Ernst O, Avni D, Athamna M, Philosoph A, Arana L, Ouro A, Hoeferlin LA, Meijler MM, Chalfant CE, Gómez-Muñoz
2016

The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer. Oncogenesis

NC Hait, D Avni, A Yamada, M Nagahashi, T Aoyagi, H Aoki, CI Dumur, Z Zelenko, EJ Gallagher, D Leroith, S Milstien, K Takabe and S Spiegel
2015